"hand-picked telehealth companies to inappropriately steer patients toward specific, high-cost medications and inflate Big Pharma's profit margins,"
"spent up to $3 million combined for partnerships with telehealth companies, who funneled patients to the manufacturers' products. ... In one instance, 100 percent of the patients routed to a virtual visit with one of Eli Lilly's chosen telehealth companies received a prescription."
"'In any other administration, it would 100 percent be the AKS stuff,' Reid said. 'It's clear there's a lawyer somewhere at HHS who has concerns about anti-kickback.'"
DTC pharmaceutical websites use selected telehealth companies to steer patients toward high-cost medications and increase manufacturers' profit margins. Partnerships between drugmakers and telehealth firms have involved payments up to $3 million combined to funnel patients toward manufacturers' products. In one reported instance, every patient routed to a virtual visit with an Eli Lilly–chosen telehealth partner received a prescription. TrumpRx has a potential relationship with BlinkRx, whose board included Donald Trump Jr. beginning February 2025. Lawmakers are concerned such relationships could violate the federal anti-kickback statute, which bars payments that induce use of federally reimbursable services. HHS legal concerns may have delayed TrumpRx's launch.
Read at Ars Technica
Unable to calculate read time
Collection
[
|
...
]